USANA Health Sciences, Inc. (USNA)

Over the past six months, USANA Health Sciences' stock price has declined, with a 44.42% decrease between December 26, 2024, and December 24, 2025. In October 2025, shares slid approximately 11% following the preliminary Q3 2025 earnings report due to weaker sales productivity and lower customer acquisition in the Hiya direct-to-consumer business. The company is undergoing a transitional period, integrating the Hiya Health acquisition and rolling out a new compensation plan. A $4.7 million charge was also planned for Q4 global cost reduction. On January 8, 2026, Kevin Guest returned to USANA Health Sciences as CEO.

USANA Health Sciences typically experiences seasonal demand for its products, usually observing strong seasonal demand in the third quarter. However, in Q3 2025, the company reported softer sales, which was noted as a concern given the usual seasonal trends.

USANA Health Sciences, Inc. is a global direct-selling company focused on developing, manufacturing, and selling science-based nutritional, personal care, and skincare products. Its major product lines include USANA Nutritionals Optimizers for individual health needs, Essentials/CellSentials for core nutrition, Food Products for healthy weight management, Celavive skincare, and other products including business-building tools and products for prenatal, infant, and young-child age groups in China. The company distributes its products through a direct-selling model and a direct-to-consumer channel, including its Hiya Health Products subsidiary.

USANA Health Sciences has a significant international presence, operating in the Asia Pacific, the Americas, and Europe, with a global footprint extending to 25 markets. USANA products are sold in the United States, Canada, Australia, New Zealand, Hong Kong, China, Japan, Taiwan, South Korea, Singapore, Mexico, Malaysia, the Philippines, the Netherlands, the United Kingdom, Thailand, France, Belgium, Colombia, Indonesia, Germany, Spain, Romania, and Italy. In the second half of 2023, USANA expanded its operations into India.

In the past year, USANA Health Sciences has maintained a positive brand reputation through various achievements and initiatives. USANA Malaysia was recognized as the #1 Combination Dietary Supplements Brand by Euromonitor International. The company's probiotic product earned a ConsumerLab.com Seal of Approval in December 2025, and its MagneCal D product received the same recognition in November 2025. USANA also extended its partnership with the Jamaican Bobsled Team in December 2025. Executive Chairman Kevin Guest emphasized the importance of leading with authenticity, empathy, and moral clarity, and shared an instance where the company scrapped a multimillion-dollar product batch to uphold its quality standards. In January 2024, USANA concluded its 20-year sponsorship of the USANA Amphitheatre to redirect its focus and resources towards other vital community-building projects, such as the USANA Kids Eat program.

USANA Health Sciences, Inc. has a diverse ownership structure, with institutional shareholders holding 60.89% of the company's stock. Major institutional owners include BlackRock, Inc., Pzena Investment Management Llc, Renaissance Technologies Llc, Vanguard Group Inc, Dimensional Fund Advisors Lp, IJR - iShares Core S&P Small-Cap ETF, State Street Corp, Morgan Stanley, and Charles Schwab Investment Management Inc. Insiders hold a substantial portion of the company, with Dr. Myron W. Wentz, the founder, being the largest individual shareholder.